Sign Up to Receive Your Personalised Learning Resources

JOURNALS
SARS-CoV-2 mRNA vaccination associated with increased survival in patients with lung cancer and melanoma treated with immune checkpoint inhibitors
Start Learning
Advancing upper gastrointestinal cancer care: Insights from Dr Ken Kato on Japan’s clinical research and future innovations
Finding the target in METex14 skipping NSCLC – optimizing patient benefit through best practice
Sponsored content
Immunotherapy for early-stage, resectable NSCLC: From clinical trial data to guidelines
CE/CME ACCREDITED
New study shows combined power of deep learning and radiologists in prostate cancer detection
Mesothelioma and Immunotherapies
Greatest hits of 2024
Perspectives on EGFR-mutant and wildtype NSCLC: Tailoring treatment advances in late-stage disease
CE/CME ACCREDITED
Optimizing treatment of CML in the first-line setting and beyond: Insights from EHA 2024 and ESH-iCMLf 2024
Focus on leukemia – Felix and ASC4FIRST
Focused insights: Data implications of ADCs in NSCLC treatment
CE/CME ACCREDITED
Advancing upper gastrointestinal cancer care: Insights from Dr Ken Kato on Japan’s clinical research and future innovations
Finding the target in METex14 skipping NSCLC – optimizing patient benefit through best practice
Sponsored content
Immunotherapy for early-stage, resectable NSCLC: From clinical trial data to guidelines
CE/CME ACCREDITED
New study shows combined power of deep learning and radiologists in prostate cancer detection
Mesothelioma and Immunotherapies
Greatest hits of 2024
Perspectives on EGFR-mutant and wildtype NSCLC: Tailoring treatment advances in late-stage disease
CE/CME ACCREDITED
Optimizing treatment of CML in the first-line setting and beyond: Insights from EHA 2024 and ESH-iCMLf 2024
Focus on leukemia – Felix and ASC4FIRST
Focused insights: Data implications of ADCs in NSCLC treatment
CE/CME ACCREDITED
Advancing upper gastrointestinal cancer care: Insights from Dr Ken Kato on Japan’s clinical research and future innovations
Finding the target in METex14 skipping NSCLC – optimizing patient benefit through best practice
Sponsored content
Immunotherapy for early-stage, resectable NSCLC: From clinical trial data to guidelines
CE/CME ACCREDITED
New study shows combined power of deep learning and radiologists in prostate cancer detection
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Trastuzumab deruxtecan shows clinical benefit in patients with HER2-ultralow metastatic breast cancer
View
Capivasertib + paclitaxel for metastatic triple-negative breast cancer did not meet threshold for improving overall survival
View
Tools to guide treatment decisions in early breast cancer: Genomic testing and emerging role of MRD
View
Niraparib as first-line maintenance treatment in ovarian cancer
View
12 million reasons for action: Transforming cancer care for women
View
From clinical trials to clinical practice: Applying CDK4/6 inhibitors in HR+/HER2– early breast cancer
View
Clinical advancements and key presentations: ESGO 2024
View
Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management
View
Dr Pooja Ghatalia on research, mentorship and patient-centered care: touchONCOLOGY Future Leader 2025
View
Trastuzumab Deruxtecan for the Treatment of HER2-low Advanced or Metastatic Breast Cancer
View
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGY
Sign me up!